Table 3

Tumor response summary by HER2 status*

HER2 statusTotal patients in subgroupResponders, n (%)
IHC 3+2218 (82)
IHC 2+127 (58)
IHC “positive”53 (60)
FISH+1210 (83)
FISH137 (54)
HER2 statusTotal patients in subgroupResponders, n (%)
IHC 3+2218 (82)
IHC 2+127 (58)
IHC “positive”53 (60)
FISH+1210 (83)
FISH137 (54)

*IHC tests were performed in 39 patients and FISH was performed in 25.

†Reported as positive without further subcategorization.

Abbreviations: HER2 = human epidermal growth factor receptor 2; IHC = immunohistochemistry; FISH = fluorescence in situ hybridization.

Table 3

Tumor response summary by HER2 status*

HER2 statusTotal patients in subgroupResponders, n (%)
IHC 3+2218 (82)
IHC 2+127 (58)
IHC “positive”53 (60)
FISH+1210 (83)
FISH137 (54)
HER2 statusTotal patients in subgroupResponders, n (%)
IHC 3+2218 (82)
IHC 2+127 (58)
IHC “positive”53 (60)
FISH+1210 (83)
FISH137 (54)

*IHC tests were performed in 39 patients and FISH was performed in 25.

†Reported as positive without further subcategorization.

Abbreviations: HER2 = human epidermal growth factor receptor 2; IHC = immunohistochemistry; FISH = fluorescence in situ hybridization.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close